Clinical trial
Patient-Reported Health Status Assessment Using the Kansas City Cardiomyopathy Questionnaire for Early Detection of Heart Failure Worsening
NCT07552142 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient-Reported Health Status Assessment Using the Kansas City Cardiomyopathy Questionnaire for Early Detection of Heart Failure Worsening
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 1, 2025
- Completion date
- April 1, 2028
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.